We retired this podcast, because we couldn't parse it for 10 consecutive times.
Date | Title & Description | Contributors |
---|---|---|
2022-10-05 | C. Michael Gibson and Nicholas Curzen discuss whether routine pressure-wire assessment influences the use of coronary angiography for diagnosing chest pain. |
|
2022-09-14 | C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial. |
|
2022-09-07 | C. Michael Gibson and Ole Fröbert discuss the potential for influenza vaccination in post-MI patients. |
|
2022-08-25 | C. Michael Gibson and Wan Azman Wan Ahmad discuss a sirolimus-versus a paclitaxel-coated balloon in de novo coronary lesions. |
|
2022-08-10 | C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without diabetes. |
|
2022-08-03 | C. Michael Gibson and Matthias Götberg review 5-year findings after iFR- versus FFR-guided PCI. |
|
2022-07-20 | Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD. |
|
2022-07-06 |
Episode 151: Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk Desai and Anahita Dua discuss highlights from a CME program on reducing thrombosis risks in patients with PAD post-revascularization. Claim credit: https://bit.ly/3QTpBt6. Supported by an educational grant from Janssen Scientific Affairs, LLC. |
|
2022-07-06 | C. Michael Gibson and Steffen Desch discuss whether immediate angiography is warranted after out-of-hospital cardiac arrest. |
|
2022-06-22 | C. Michael Gibson and David Kandzari discuss PCI outcomes among patients at prohibitive risk for CABG. |
|